Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to an Adequate Trial of Antidepressant

NCT00174577 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT00174577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to an Adequate Trial of Antidepressant
Lead sponsor
Rhode Island Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2003
Completion date
February 28, 2005
Enrollment
84
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depression